Molecular Diagnostics Market to Become Worth US$18.9 bn by 2025 by poojam · September 25 Wholesale Soccer Jerseys China , 2018
The global molecular diagnostics market has been foretold in a report by Transparency Market Research (TMR) to demonstrate a reasonably consolidated nature of its vendor landscape as three leading companies had secured a combined share of 54.0% in 2015. The three companies, viz. F. Hoffmann-La Roche AG, Abbott Laboratories Wholesale Soccer Jerseys , and Danaher Corporation had showcased their dominance in the recent past. In order to develop innovative molecular diagnostic kits with enhanced functionalities, you could see a number of companies making massive research and development investments. Leading companies have been largely focusing on widening their product portfolios and tactical mergers and acquisitions to stay ahead of the competition.
After closely monitoring the global molecular diagnostics market, TMR has prophesied it to expand at an 11.6% CAGR during the forecast tenure 2016-2025 to garner an US$18.9 b Delay in Approvals Leads to Paucity of Advanced Molecular Diagnostics
The revenue growth of the international molecular diagnostics market has been prognosticated to be hampered by prolonged approvals required from the FDA and other regulatory authorities. This has created a dearth of sophisticated molecular diagnostics tools for clinicians to treat chronic diseases and infections. Moreover, lack of promising reimbursement policies has been projected to discourage the adoption of molecular diagnostics.
Request Report Brochur 3
However, the demand for molecular diagnostics has been prophesied to gain strength on the back of the rising prominence of personalized therapies in several developed countries. Additiona